J&J Recalls Infant Tylenol Over Dosing System Flaw
The recall is the latest in a long series for J&J’s consumer division involving Tylenol and other over-the-counter brands for adults and children.
No adverse events have been reported in association with Friday’s Tylenol recall, J&J said.
Copyright 2026 Reuters. Click for restrictions.
Popular Today
- HSBC Executive Strikes Back in Court Fight Over Poaching Claims
- Warren, Hawley Press Insurers Over Closed, Unpaid Claims
- Will California’s New Smoke Claims Law Create a Recovery Bottleneck?
- Anxiety Over Gas Prices Points to ‘Looming EV Comeback’ in US
Popular This Month
- Apollo’s Rowan Blasts Regulators for Handling of Walter Insurers
- Londoners Find ‘Horrendous’ Cracks in Their Homes After Successive Heat Waves
- The Great Hemp Reset: How the Federal Ban on Intoxicating Hemp Products Will Reshape Risk and Coverage
- Are We Training Claims Adjusters or Claims Processors?